BioMimetic Therapeutics Inc. (BMTI) Stock Quote

Detailed Quote for BioMimetic Therapeutics Inc. (BMTI)

After Hours: $ 2.13

0.00 (0.00%)

Volume: 100

4:00 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

April 8, 2011

Close: 14.49

52 Week Low

January 11, 2012

Close: 1.87

Today

Last Price
2.13

Change $
0.10

Change %
4.48%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
2.20

High
2.219

Low
2.11

Prev Close
2.23

Last Trade
2/10/12

Volume
291.38 k

52 Wk Hi
14.49

52 Wk Low
1.87

Market Cap
59.76 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
28,056,627

EPS (TTM)
-1.18

PE Ratio
N/A

close Exchange Information Listed On Nasdaq Global Select (NGS) Exchange
NGS

News and Media for BioMimetic Therapeutics Inc. (BMTI)

Sector News | Topic News

News for BMTI

Wed, Feb 08, 2012

9:25 AM

BioMimetic Therapeutics, Inc. to Introduce Augmatrix(tm) Biocomposite Bone Graft Product Line at AAOS - Business Wire

Mon, Feb 06, 2012

4:00 PM

BioMimetic Therapeutics, Inc. to Highlight Product Development Activities at ORS and AAOS Meetings - Business Wire

Tue, Jan 10, 2012

11:00 AM

BioMimetic Therapeutics, Inc. to Present at the 30th Annual J.P. Morgan Healthcare Conference - Business Wire

Tue, Jan 03, 2012

4:11 PM

BioMimetic Therapeutics Announces Approval to Market GEM 21S® in the European Union - Business Wire

4:04 PM

BioMimetic Therapeutics Receives Augment® Bone Graft PMA Response Letter from FDA - Business Wire

Wed, Jul 13, 2011

5:51 PM

Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in BioMimetic Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the September 6, 2011 Lead Plaintiff Deadline - Marketwire

Mon, Jul 11, 2011

12:20 PM

Holzer Holzer & Fistel, LLC Announces That a Shareholder Class Action Has Been Filed on Behalf of Purchasers of BioMimetic Therapeutics, Inc. Securities - Marketwire

Fri, Jul 08, 2011

6:37 PM

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) - Marketwire

4:11 PM

Izard Nobel LLP Announces Class Action Lawsuit Against BioMimetic Therapeutics, Inc. - Marketwire

Thu, Jul 07, 2011

6:57 PM

Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioMimetic Therapeutics, Inc. of Class Action Lawsuit and the September 6, 2011 Lead Plaintiff Deadline - Marketwire

More News for BMTI >>

Tags for BioMimetic Therapeutics Inc.

Research stocks or mutual funds related to BioMimetic Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to BMTI. The keywords below have been associated to BMTI by either user submission or electronic means.

guided tissue regeneration bleeding gums periodontal pharmaceutical market pharmaceuticals companies tissue repair generic pharmaceutical pharmaceutical investment tissue engineering pharmaceutical research and development healthy gums pharma marketing gum infection pharma manufacturing pharma license kv pharmaceutical company periodontal surgery receding gums pharmaceutical cro treating gingivitis chronic gingivitis biomimetic pharmaceutical distributors treating gum disease Surgical and Medical Instrument Manufacturing (339112) biotech corporation pharmaceutical development pharmaceutical reports pharmaceutical magazine pdgf receptor gingivitis treatment collagen pharma r&d pharmaceutical industry news pharmaceutical manufacturing software reversing gingivitis contract pharmaceutical pharmaceutical industry bone graft dental bone grafting pharmaceutical sale Epidermal growth factor pharmaceutical advances pharmaceutical distributor bone substitute receding gum symptoms of gum disease pharmaceutical out licensing Healthcare bone substitutes